These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30537258)

  • 41. Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
    Fattahi MJ; Abdollahi M; Agha Mohammadi A; Rastkari N; Khorasani R; Ahmadi H; Tofighi Zavareh F; Sedaghat R; Tabrizian N; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2015; 37(6):535-40. PubMed ID: 26584020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tau and amyloid beta differentially affect the innate immune genes expression in Drosophila models of Alzheimer's disease and β- D Mannuronic acid (M2000) modulates the dysregulation.
    Barati A; Masoudi R; Yousefi R; Monsefi M; Mirshafiey A
    Gene; 2022 Jan; 808():145972. PubMed ID: 34600048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under
    Tahmasebi S; Neishaboori H; Jafari D; Faghihzadeh E; Esmaeilzadeh A; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):562-570. PubMed ID: 34314306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells.
    Yuengsrigul A; Chin TW; Nussbaum E
    Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):559-66. PubMed ID: 10619350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation.
    Gualdoni GA; Kovarik JJ; Hofer J; Dose F; Pignitter M; Doberer D; Steinberger P; Somoza V; Wolzt M; Zlabinger GJ
    Biochim Biophys Acta; 2014 Jan; 1840(1):95-105. PubMed ID: 24035785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
    Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
    Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.
    Roozbehkia M; Mahmoudi M; Aletaha S; Rezaei N; Fattahi MJ; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
    Int Immunopharmacol; 2017 Nov; 52():191-196. PubMed ID: 28938189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Guluronic Acid (G2013), As a New Anti-inflammatory Drug on Gene Expression of Pro-inflammatory and Anti-inflammatory Cytokines and Their Transcription Factors in Rheumatoid Arthritis Patients.
    Bakhtiari T; Azarian S; Ghaderi A; Ahmadzadeh A; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):639-648. PubMed ID: 32245307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.
    Wang XD; Wang YL; Gao WF
    Int J Clin Exp Pathol; 2015; 8(7):7929-36. PubMed ID: 26339358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-inflammatory Property of β-D-Mannuronic Acid (M2000) on Expression and Activity of Matrix Metalloproteinase-2 and -9 through CD147 Molecule in Phorbol Myristate Acetate-differentiated THP-1 Cells.
    M Farahani M; Motevaseli E; Maghsood F; Heidari-Kharaji M; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):443-451. PubMed ID: 29149784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of Biochemical Determinants in Multiple Sclerosis Patients Following the Oral Administration of β-D-Mannuronic Acid (M2000).
    Nikouei Moghaddam MR; Movahedi M; Bananej M; Najafi S; Moghadam NB; Saadat P; Mokhtarian F; Mirshafiey A
    Curr Drug Discov Technol; 2021; 18(5):e17092020186049. PubMed ID: 32964823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-hypertensive drugs alter cytokine production from preeclamptic placentas and peripheral blood mononuclear cells.
    Xu B; Thornton C; Makris A; Ogle R; Hennessy A
    Hypertens Pregnancy; 2007; 26(3):343-56. PubMed ID: 17710582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
    Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
    Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.
    Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E
    Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of serum cytokine levels in patients with myelodysplastic syndromes.
    Verhoef GE; De Schouwer P; Ceuppens JL; Van Damme J; Goossens W; Boogaerts MA
    Leukemia; 1992 Dec; 6(12):1268-72. PubMed ID: 1280751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anti-inflammatory effect of Gigukjiwhangwhangami through the inhibition of nuclear factor-kappaB activation in the peripheral blood mononuclear cells of patients with cerebral infarction.
    Kim SJ; Jeong HJ; Moon PD; Lee KM; Lee MG; Moon BS; An NH; Hong SH; Na HJ; Jeon H; Kim HM; Um JY
    Biol Pharm Bull; 2006 Nov; 29(11):2251-5. PubMed ID: 17077523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide.
    Shannon E; Noveck R; Sandoval F; Kamath B
    Immunopharmacol Immunotoxicol; 2008; 30(3):447-57. PubMed ID: 18668392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.
    Bruin KF; Hommes DW; Jansen J; Tytgat GN; Wouter ten Cate J; van Deventer SJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):791-5. PubMed ID: 7496871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary sarcoidosis: patterns of cytokine release in vitro.
    Prior C; Knight RA; Herold M; Ott G; Spiteri MA
    Eur Respir J; 1996 Jan; 9(1):47-53. PubMed ID: 8834333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.